This bill reauthorizes, enhances funding for, and streamlines commercialization pathways for the federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs through 2030.
Edward "Ed" Markey
Senator
MA
The SBIR/STTR Reauthorization Act of 2025 extends and significantly enhances federal programs supporting small business innovation and technology transfer through 2030. The bill increases mandatory funding levels for the SBIR and STTR programs, establishes new paid fellowships to build a skilled workforce, and streamlines the path for small businesses to commercialize their federally-funded research with the government. Furthermore, it strengthens oversight, transparency, and accountability across these critical research and development initiatives.
The SBIRSTTR Reauthorization Act of 2025 is essentially a massive, decade-long commitment to small business innovation, ensuring that two critical federal research programs—the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs—don’t just continue, but get significantly more funding.
This bill reauthorizes both the SBIR and STTR programs indefinitely, removing previous expiration dates. It also extends the popular FAST Program, which helps small businesses access these grants, until September 30, 2030. Think of it as renewing the subscription for the federal government's primary high-tech startup incubator, but with a much bigger budget.
This is the biggest headline change: the bill mandates a steady, significant increase in how much money federal agencies must set aside for these programs. Right now, agencies dedicate a percentage of their R&D budgets to SBIR and STTR. This bill ratchets that up over the next decade.
For SBIR, the minimum required funding starts climbing in Fiscal Year 2026, eventually hitting 7 percent of an agency’s budget by Fiscal Year 2032 (up from the current level). The STTR program sees a similar, if smaller, climb, reaching 1 percent by 2032. For a small engineering firm in the Midwest trying to land a contract with NASA, this means the pool of available, guaranteed federal funding is going to get noticeably deeper year after year.
One of the biggest frustrations for small businesses winning these grants is transitioning their successful research (Phase II) into a product the government actually buys (Phase III). The bill tackles this bottleneck head-on.
First, it requires the Small Business Administration (SBA) to work with agencies like the Department of Defense (DOD) to train federal contracting officers on how to properly use Phase III agreements. This training should help clear up confusion about data rights and how to award those final contracts. To make sure the message sticks, every agency running an SBIR/STTR program must now designate a Technology Commercialization Official (Sec. 303). This person is tasked with guiding awardees on how to sell their new tech and helping connect them with new markets.
For the small business owner, this means less time fighting bureaucratic red tape and more time selling their innovation, because the government buyers are now required to be educated on how to buy it.
Small businesses will also see more control over their Technical and Business Assistance (TABA) funds. Previously, agencies often dictated who provided this support. Now, companies with Phase I or Phase II awards can choose their own vendors and even use the money for internal staffing, training, or cybersecurity help (Sec. 204). The funding limits are also increased: up to $6,500 for Phase I projects and $50,000 for Phase II projects.
To build the talent pipeline, agencies can now offer paid fellowship and internship opportunities for undergraduate, graduate, and post-doc students within small businesses that have completed Phase II (Sec. 202). This is a win-win: small businesses get highly skilled, temporary help, and students get real-world experience in high-tech environments.
Crucially, the bill mandates focused outreach to encourage participation from women, socially disadvantaged individuals, and researchers at Minority Institutions and Hispanic-serving institutions (Sec. 203). This is a clear move to make sure the increased funding reaches a broader range of innovators.
While the bill is mostly about expansion, it tightens the rules on who can receive these funds, particularly when foreign investment is involved. Section 505 codifies new safeguards, stating that a small business majority-owned by venture capital or private equity firms can be disqualified from receiving an SBIR award if the SBA determines it is owned or controlled by a “covered foreign entity.”
This provision is aimed at protecting U.S. technology from being developed with federal funds only to fall under the control of entities deemed a national security risk. For investment firms, this means a new layer of due diligence is required to ensure their portfolio companies receiving SBIR funds do not run afoul of the broad definitions of “covered foreign entity.”
Finally, the bill aims to speed up the process for the National Institutes of Health (NIH) through a new pilot program designed to get money into the hands of awardees faster—aiming for funding release within 90 days of an award notice (Sec. 504). However, in a slight step back for transparency, the required report on the timeliness of awards is being reduced from every three years to every eleven years (Sec. 503). While agencies must now report the average time it takes to review proposals, the reduced frequency means less regular oversight on how quickly they are moving.